Multivariable analysis of clinical and laboratory data manifestations predicting severity and mortality risk in patients with Coronavirus disease 2019 in the mountainous west of Iran: a retrospective single-center study

[1] Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020; 395(10225):689–97. WuJT LeungK LeungGM Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study Lancet 2020 395 10225 689 97 10.1016/S0140-6736(20)30260-9 Search in Google Scholar

[2] Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health – the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020; 91:264–6. HuiDS AzharEI MadaniTA NtoumiF KockR DarO The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health – the latest 2019 novel coronavirus outbreak in Wuhan, China Int J Infect Dis 2020 91 264 6 10.1016/j.ijid.2020.01.009712833231953166 Search in Google Scholar

[3] Gralinski LE, Menachery VD. Return of the coronavirus: 2019-nCoV. Viruses. 2020; 12:135. doi: 10.3390/v12020135 GralinskiLE MenacheryVD Return of the coronavirus: 2019-nCoV Viruses 2020 12 135 10.3390/v12020135 707724531991541 Open DOISearch in Google Scholar

[4] Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323:1239–42. WuZ McGooganJM Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention JAMA 2020 323 1239 42 10.1001/jama.2020.264832091533 Search in Google Scholar

[5] Pun M, Turner R, Strapazzon G, Brugger H, Swenson ER. Lower incidence of COVID-19 at high altitude: facts and confounders. High Alt Med Biol. 2020; 21:217–22. PunM TurnerR StrapazzonG BruggerH SwensonER Lower incidence of COVID-19 at high altitude: facts and confounders High Alt Med Biol 2020 21 217 22 10.1089/ham.2020.011432716669 Search in Google Scholar

[6] Chen H, Qin L, Wu S, Xu W, Gao R, Zhang X. Clinical characteristics and laboratory features of COVID-19 in high altitude areas: a retrospective cohort study. PLoS One. 2021; 16:e0249964. doi: 10.1371/journal.pone.0249964 ChenH QinL WuS XuW GaoR ZhangX Clinical characteristics and laboratory features of COVID-19 in high altitude areas: a retrospective cohort study PLoS One 2021 16 e0249964 10.1371/journal.pone.0249964 813093334003821 Open DOISearch in Google Scholar

[7] Karimi F, Vaezi AA, Qorbani M, Moghadasi F, Gelsfid SH, Maghoul A, et al. Clinical and laboratory findings in COVID-19 adult hospitalized patients from Alborz province/Iran: comparison of rRT-PCR positive and negative. BMC Infect Dis. 2021;21:256. doi: 10.1186/s12879-021-05948-5 KarimiF VaeziAA QorbaniM MoghadasiF GelsfidSH MaghoulA Clinical and laboratory findings in COVID-19 adult hospitalized patients from Alborz province/Iran: comparison of rRT-PCR positive and negative BMC Infect Dis 2021 21 256 10.1186/s12879-021-05948-5 794866133706699 Open DOISearch in Google Scholar

[8] Pourabdollah Toutkaboni M, Askari E, Khalili N, Tabarsi P, Jamaati H, Velayati AA, et al. Demographics, laboratory parameters and outcomes of 1061 patients with coronavirus disease 2019: a report from Tehran, Iran. New Microbes New Infect. 2020; 38:100777. doi: 10.1016/j.nmni.2020.100777 Pourabdollah ToutkaboniM AskariE KhaliliN TabarsiP JamaatiH VelayatiAA Demographics, laboratory parameters and outcomes of 1061 patients with coronavirus disease 2019: a report from Tehran, Iran New Microbes New Infect 2020 38 100777 10.1016/j.nmni.2020.100777 753479033042553 Open DOISearch in Google Scholar

[9] Javanian M, Bayani M, Shokri M, Sadeghi-Haddad-Zavareh M, Babazadeh A, Yeganeh B, et al. Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol North of Iran: a retrospective cohort study. Rom J Intern Med. 2020; 58:161–7. JavanianM BayaniM ShokriM Sadeghi-Haddad-ZavarehM BabazadehA YeganehB Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol North of Iran: a retrospective cohort study Rom J Intern Med 2020 58 161 7 10.2478/rjim-2020-001332396143 Search in Google Scholar

[10] Mousavi SA, Rad S, Rostami T, Rostami M, Mousavi SA, Mirhoseini SA, Kiumarsi A. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study. Hematology. 2020; 25:383–8. MousaviSA RadS RostamiT RostamiM MousaviSA MirhoseiniSA KiumarsiA Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study Hematology 2020 25 383 8 10.1080/16078454.2020.183343533124971 Search in Google Scholar

[11] Raesi A, Saedi Dezaki E, Moosapour H, Saeidifard F, Habibi Z, Rahmani F, et al. Hypocalcemia in Covid-19: a prognostic marker for severe disease. Iran J Pathol. 2021; 16:144–53. RaesiA Saedi DezakiE MoosapourH SaeidifardF HabibiZ RahmaniF Hypocalcemia in Covid-19: a prognostic marker for severe disease Iran J Pathol 2021 16 144 53 10.30699/ijp.2020.130491.2442 Search in Google Scholar

[12] von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014; 61:344–9. von ElmE AltmanDG EggerM PocockSJ GøtzschePC VandenbrouckeJP STROBE Initiative The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies Int J Surg 2014 61 344 9 10.1097/EDE.0b013e3181577654 Search in Google Scholar

[13] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497–506. HuangC WangY LiX RenL ZhaoJ HuY Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 2020 395 10223 497 506 10.1016/S0140-6736(20)30183-5 Search in Google Scholar

[14] World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) [Internet]. Geneva: World Health Organization; 2020 February 16–24 [cited 2021 March 10]. Available from: https://www.who.int/publications/i/item/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19) World Health Organization Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) [Internet] Geneva World Health Organization 2020 February 16–24 [cited 2021 March 10]. Available from: https://www.who.int/publications/i/item/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19) Search in Google Scholar

[15] Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223):507–13. ChenN ZhouM DongX QuJ GongF HanY Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Lancet 2020 395 10223 507 13 10.1016/S0140-6736(20)30211-7 Search in Google Scholar

[16] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054–62. ZhouF YuT DuR FanG LiuY LiuZ Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet 2020 395 10229 1054 62 10.1016/S0140-6736(20)30566-3 Search in Google Scholar

[17] Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020: 46:846–8. RuanQ YangK WangW JiangL SongJ Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China Intensive Care Med 2020 46 846 8 10.1007/s00134-020-05991-x708011632125452 Search in Google Scholar

[18] Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–5. YangJ ZhengY GouX PuK ChenZ GuoQ Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis Int J Infect Dis 2020 94 91 5 10.1016/j.ijid.2020.03.017719463832173574 Search in Google Scholar

[19] Guan W-j, Liang W-h, Zhao Y, Liang H-r, Chen Z-s, Li Y-m, et al.; China Medical Treatment Expert Group for COVID-19. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J. 2020; 55:2000547. doi: 10.1183/13993003.00547-2020 GuanW-j LiangW-h ZhaoY LiangH-r ChenZ-s LiY-m China Medical Treatment Expert Group for COVID-19 Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis Eur Respir J 2020 55 2000547. 10.1183/13993003.00547-2020 709848532217650 Open DOISearch in Google Scholar

[20] Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single center in Wuhan city, China. Liver Int. 2020: 40:2095–103. ZhangY ZhengL LiuL ZhaoM XiaoJ ZhaoQ Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single center in Wuhan city, China Liver Int 2020 40 2095 103 10.1111/liv.1445532239796 Search in Google Scholar

[21] Xie H, Zhao J, Lian N, Lin S, Xie Q, Zhuo H. Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: a retrospective study. Liver Int. 2020; 40:1321–26. XieH ZhaoJ LianN LinS XieQ ZhuoH Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: a retrospective study Liver Int 2020 40 1321 26 10.1111/liv.14449722833332239591 Search in Google Scholar

[22] Feng G, Zheng KI, Yan Q-Q, Rios RS, Targher G, Byrne CD, et al. COVID-19 and liver dysfunction: current insights and emergent therapeutic strategies. J Clin Transl Hepatol. 2020; 8:18–24. FengG ZhengKI YanQ-Q RiosRS TargherG ByrneCD COVID-19 and liver dysfunction: current insights and emergent therapeutic strategies J Clin Transl Hepatol 2020 8 18 24 10.14218/JCTH.2020.00018 Search in Google Scholar

[23] Guan WJ, Zhong NS. Clinical characteristics of COVID-19 in China. N Engl J Med. 2020; 382:1861–2. GuanWJ ZhongNS Clinical characteristics of COVID-19 in China N Engl J Med 2020 382 1861 2 10.1056/NEJMc2005203 Search in Google Scholar

[24] Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020; 8:475–81. YangX YuY XuJ ShuH XiaJ LiuH Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Lancet Respir Med 2020 8 475 81 10.1016/S2213-2600(20)30079-5 Search in Google Scholar

[25] Wu Y, Potempa LA, El Kebir D, Filep JG. C-reactive protein and inflammation: conformational changes affect function. Biol Chem. 2015; 396:1181–97. WuY PotempaLA El KebirD FilepJG C-reactive protein and inflammation: conformational changes affect function Biol Chem 2015 396 1181 97 10.1515/hsz-2015-014926040008 Search in Google Scholar

[26] Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020; 63:364–74. LiuY YangY ZhangC HuangF WangF YuanJ Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury Sci China Life Sci 2020 63 364 74 10.1007/s11427-020-1643-8708856632048163 Search in Google Scholar

[27] Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan China. JAMA Inter Med. 2020; 180:934–43. WuC ChenX CaiY XiaJ ZhouX XuS Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan China JAMA Inter Med 2020 180 934 43 10.1001/jamainternmed.2020.0994707050932167524 Search in Google Scholar

[28] Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan China. JAMA Cardiol. 2020; 5:802–10. ShiS QinM ShenB CaiY LiuT YangF Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan China JAMA Cardiol 2020 5 802 10 10.1001/jamacardio.2020.0950709784132211816 Search in Google Scholar

[29] Deng Y, Liu W, Liu K, Fang Y-Y, Shang J, Zhou L, et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study. Chin Med J (Engl). 2020; 133:1261–7. DengY LiuW LiuK FangY-Y ShangJ ZhouL Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study Chin Med J (Engl) 2020 133 1261 7 10.1097/CM9.0000000000000824728931132209890 Search in Google Scholar

[30] Foy BH, Carlson JCT, Reinertsen E, Padros I Valls R, Pallares Lopez R, Palanques-Tost E, et al. Association of red blood cell distribution width with mortality risk in hospitalized adults with SARS-CoV-2 infection. JAMA Netw Open. 2020; 3:e2022058. doi: 10.1001/jamanetworkopen.2020.22058 FoyBH CarlsonJCT ReinertsenE PadrosI VallsR Pallares LopezR Palanques-TostE Association of red blood cell distribution width with mortality risk in hospitalized adults with SARS-CoV-2 infection JAMA Netw Open 2020 3 e2022058 10.1001/jamanetworkopen.2020.22058 751205732965501 Open DOISearch in Google Scholar

[31] Patel HH, Patel HR, Higgins JM. Modulation of red blood cell population dynamics is a fundamental homeostatic response to disease. Am J Hematol. 2015; 90:422–8. PatelHH PatelHR HigginsJM Modulation of red blood cell population dynamics is a fundamental homeostatic response to disease Am J Hematol 2015 90 422 8 10.1002/ajh.23982471748925691355 Search in Google Scholar

[32] Anderson JL, Ronnow BS, Horne BD, Carlquist JF, May HT, Bair TL, et al.; Intermountain Heart Collaborative (IHC) Study Group. Usefulness of a complete blood count-derived risk score to predict incident mortality in patients with suspected cardiovascular disease. Am J Cardiol. 2007; 99:169–74. AndersonJL RonnowBS HorneBD CarlquistJF MayHT BairTL Intermountain Heart Collaborative (IHC) Study Group Usefulness of a complete blood count-derived risk score to predict incident mortality in patients with suspected cardiovascular disease Am J Cardiol 2007 99 169 74 10.1016/j.amjcard.2006.08.01517223413 Search in Google Scholar

[33] Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJV, Pfeffer MA, et al.; CHARM Investigators. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007; 50:40–47. FelkerGM AllenLA PocockSJ ShawLK McMurrayJJV PfefferMA CHARM Investigators Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank J Am Coll Cardiol 2007 50 40 47 10.1016/j.jacc.2007.02.06717601544 Search in Google Scholar

[34] Perlstein TS, Weuve J, Pfeffer MA, Beckman JA. Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med. 2009; 169:588–94. PerlsteinTS WeuveJ PfefferMA BeckmanJA Red blood cell distribution width and mortality risk in a community-based prospective cohort Arch Intern Med 2009 169 588 94 10.1001/archinternmed.2009.55338757319307522 Search in Google Scholar

[35] Topaz G, Kitay-Cohen Y, Peled L, Gharra W, Kaminer K, Eitan M, et al. The association between red cell distribution width and poor outcomes in hospitalized patients with influenza. J Crit Care. 2017; 41:166–9. TopazG Kitay-CohenY PeledL GharraW KaminerK EitanM The association between red cell distribution width and poor outcomes in hospitalized patients with influenza J Crit Care 2017 41 166 9 10.1016/j.jcrc.2017.05.01428554095 Search in Google Scholar

[36] Karagoz E, Ulcay A, Tanoglu A, Kara M, Turhan V, Erdem H, et al. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients. Eur J Gastroenterol Hepatol. 2014; 26:1320–4. KaragozE UlcayA TanogluA KaraM TurhanV ErdemH Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients Eur J Gastroenterol Hepatol 2014 26 1320 4 10.1097/MEG.000000000000020325210777 Search in Google Scholar

[37] Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik JM. Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med. 2009; 169:515–23. PatelKV FerrucciL ErshlerWB LongoDL GuralnikJM Red blood cell distribution width and the risk of death in middle-aged and older adults Arch Intern Med 2009 169 515 23 10.1001/archinternmed.2009.11276504019273783 Search in Google Scholar

[38] Patel KV, Semba RD, Ferrucci L, Newman AB, Fried LP, Wallace RB, et al. Red cell distribution width and mortality in older adults: a meta-analysis. J Gerontol A Biol Sci Med Sci. 2010; 65:258–65. PatelKV SembaRD FerrucciL NewmanAB FriedLP WallaceRB Red cell distribution width and mortality in older adults: a meta-analysis J Gerontol A Biol Sci Med Sci 2010 65 258 65 10.1093/gerona/glp163282228319880817 Search in Google Scholar

[39] Salvagno GL, Sanchis-Gomar F, Picanza A, Lippi G. Red blood cell distribution width: a simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci. 2015; 52:86–105. SalvagnoGL Sanchis-GomarF PicanzaA LippiG Red blood cell distribution width: a simple parameter with multiple clinical applications Crit Rev Clin Lab Sci 2015 52 86 105 10.3109/10408363.2014.99206425535770 Search in Google Scholar

[40] Chaudhury A, Miller GD, Eichner D, Higgins JM. Single-cell modeling of routine clinical blood tests reveals transient dynamics of human response to blood loss. Elife. 2019; 8:e48590. doi: 10.7554/eLife.48590 ChaudhuryA MillerGD EichnerD HigginsJM Single-cell modeling of routine clinical blood tests reveals transient dynamics of human response to blood loss Elife 2019 8 e48590 10.7554/eLife.48590 691748831845889 Open DOISearch in Google Scholar

[41] Spiezia L, Boscolo A, Poletto F, Cerruti L, Tiberio I, Campello E, et al. COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost. 2020; 120:998–1000. SpieziaL BoscoloA PolettoF CerrutiL TiberioI CampelloE COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure Thromb Haemost 2020 120 998 1000 10.1055/s-0040-1710018729527232316063 Search in Google Scholar

[42] Higgins JM, Mahadevan L. Physiological and pathological population dynamics of circulating human red blood cells. Proc Natl Acad Sci U S A. 2010; 107:20587–92. HigginsJM MahadevanL Physiological and pathological population dynamics of circulating human red blood cells Proc Natl Acad Sci U S A 2010 107 20587 92 10.1073/pnas.1012747107299669321059904 Search in Google Scholar

[43] Cohen RM, Franco RS, Khera PK, Smith EP, Lindsell CJ, Ciraolo PJ, et al. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood. 2008; 112:4284–91. CohenRM FrancoRS KheraPK SmithEP LindsellCJ CiraoloPJ Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c Blood 2008 112 4284 91 10.1182/blood-2008-04-154112258199718694998 Search in Google Scholar

[44] Sun J-K, Zhang W-H, Zou L, Liu Y, Li J-J, Kan X-H, et al. Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease 2019. Aging (Albany NY). 2020; 12:11287–95. SunJ-K ZhangW-H ZouL LiuY LiJ-J KanX-H Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease 2019 Aging (Albany NY) 2020 12 11287 95 10.18632/aging.103526734346832589164 Search in Google Scholar

[45] Di Filippo L, Formenti AM, Rovere-Querini P, Carlucci M, Conte C, Ciceri F, et al. Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19. Endocrine. 2020; 68:475–8. Di FilippoL FormentiAM Rovere-QueriniP CarlucciM ConteC CiceriF Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19 Endocrine 2020 68 475 8 10.1007/s12020-020-02383-5729257232533508 Search in Google Scholar

[46] Liu J, Han P, Wu J, Gong J, Tian D. Prevalence and predictive value of hypocalcemia in severe COVID-19 patients. J Infect Pub Health. 2020; 13:1224–8. LiuJ HanP WuJ GongJ TianD Prevalence and predictive value of hypocalcemia in severe COVID-19 patients J Infect Pub Health 2020 13 1224 8 10.1016/j.jiph.2020.05.029730673332622796 Search in Google Scholar

[47] Rahmani B, Patel S, Seyam O, Gandhi J, Reid I, Smith N, Khan SA. Current understanding of tumor lysis syndrome. Hematol Oncol. 2019; 37:537–47. RahmaniB PatelS SeyamO GandhiJ ReidI SmithN KhanSA Current understanding of tumor lysis syndrome Hematol Oncol 2019 37 537 47 10.1002/hon.266831461568 Search in Google Scholar

[48] Sharma V, Singh AP, Singh AP. Therapeutic approaches in COVID-19 followed before arrival of any vaccine. Mater Today Proc. 2022; 48:1258–64. doi: 10.1016/j.matpr.2021.08.265 SharmaV SinghAP SinghAP Therapeutic approaches in COVID-19 followed before arrival of any vaccine Mater Today Proc 2022 48 1258 64 10.1016/j.matpr.2021.08.265 841345734493973 Open DOISearch in Google Scholar

[49] Venkatasubbaiah M, Dwarakanadha Reddy P, Satyanarayana SV. Literature-based review of the drugs used for the treatment of COVID-19. Curr Med Res Pract. 2020; 10:100–9. VenkatasubbaiahM Dwarakanadha ReddyP SatyanarayanaSV Literature-based review of the drugs used for the treatment of COVID-19 Curr Med Res Pract 2020 10 100 9 10.1016/j.cmrp.2020.05.013730106432572376 Search in Google Scholar

[50] Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020; 17:543–58. NishigaM WangDW HanY LewisDB WuJC COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives Nat Rev Cardiol 2020 17 543 58 10.1038/s41569-020-0413-9737087632690910 Search in Google Scholar